Survival and long-term health and cognitive outcomes after low-grade glioma.
about
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivorsMAPK pathway activation in pilocytic astrocytomaSubsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapyRecruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE).Intracranial cystic lesions: a review.Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.Pediatric low-grade gliomas: how modern biology reshapes the clinical field.Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study.Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.Life satisfaction in adult survivors of childhood brain tumors.Challenging issues in pediatric oncologyWhite matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade gliomaDelayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.Prospective longitudinal evaluation of emotional and behavioral functioning in pediatric patients with low-grade glioma treated with conformal radiation therapy.Children's Oncology Group L991 final study report: Establishing an important benchmark for assessing late effects of trimodality care of pediatric patients treated for high grade gliomasImpact of vision loss among survivors of childhood central nervous system astroglial tumors.Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumoursWhole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1.Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas.The molecular and cell biology of pediatric low-grade gliomas.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Advances in the management of low-grade gliomas.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.Multidisciplinary rehabilitation for children with brain tumors: A systematic review.Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.Cognitive outcomes among survivors of focal low-grade brainstem tumors diagnosed in childhood.Interventions for managing weight change following paediatric acquired brain injury: a systematic review.The impact of age and race on longevity in pediatric astrocytic tumors: A population-based study.Non-graduation after comprehensive school, and early retirement but not unemployment are prominent in childhood cancer survivors-a Finnish registry-based study.Integrating RNA sequencing into neuro-oncology practice.Use of endocrinological and neurological medication among 5-year survivors of young onset brain tumors.Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
P2860
Q26825655-954FCADB-00D7-45F6-8587-6D5CECAE36B5Q27006028-DD435FEA-05A4-43BF-83D5-B267B4CF85F5Q30389898-50453C44-DFBA-4180-ADF2-B727A7537FEAQ30582316-AC5D525A-FECB-4157-B3A6-665BECEF9298Q30841513-51D1B2E9-06F8-415D-8C69-0276035712A7Q33600115-DF8A9407-04CA-4950-A083-CFDEA70E330CQ33610906-A41C32D5-CFAD-4290-BDF4-27DF263139FAQ33847771-54810FEA-0C21-49F5-84F3-51828B31E2EFQ34342321-F980B250-9988-4D73-8D0B-08B7AA380063Q34354839-C086F4C2-1EB8-4CF8-9037-239DB7FD365BQ34794835-A3C69571-CFC5-444E-B41D-C55FFC197E1EQ35602419-8940A1E3-0F4B-4C65-B3CC-2E75A9D2E755Q35788851-1A16732C-F5A8-4554-80D2-0B5EA9DFE465Q35832560-92FCC7EC-0FFB-436C-8616-F95EE6D119FEQ35870174-CB23B62D-F190-4CE1-972E-D6992CBDF82AQ36303023-D154DBB1-8DF5-46B4-BDCB-9745289B2B97Q36508053-B1588615-F048-42F2-9C05-98064F046171Q36609635-41B15D62-68CD-414A-B386-DAB1BE494229Q36939200-B6346C20-285F-47D1-B82E-2D8B443D1CD4Q37055286-180DC6A7-39B0-45F2-AF46-D6E0CC3F31D1Q37615744-D9D01723-B231-423A-BE36-86576ABF34FAQ37950470-ADBFCDB3-0033-4D25-8D11-589BF245EABCQ38043420-CA33F48B-5C11-441F-AFC1-E2D3879588DCQ38102568-F945D87E-DF28-41AE-BACE-B7B88A75CC10Q38203283-D2DA3B50-9413-49FB-8D7A-6CE3132530C0Q38219898-B3100C99-1BE0-4CD9-88D2-35D492B473D6Q38231122-A503B664-A418-4463-A303-3F93320D0778Q38266418-872323F5-657F-46D1-846C-A11D809861CEQ38315617-3D2747C2-7108-4B7E-94AF-B97AB83A30FBQ38556904-EE40FD55-1C6E-4D8D-AAA6-240B28820218Q38661348-AE17C0CE-6F65-4048-82DA-FD45D1AA7ABFQ38678301-A579CF51-6561-4ED4-A83F-551F9261CB69Q38679142-05DDE02B-BBC0-4AE0-B3F5-0B13CD263688Q38867367-7D0AAAF8-F83F-4CE8-BD7D-8CC11301E72FQ38887619-111B0E31-D77B-4029-A25B-93ABC1FF8E32Q39020317-FDC986A2-D36A-4865-8041-BD5DBEFB7E46Q39313862-99619508-83D3-406D-AEAA-42334E111F53Q39459649-C7EAA16A-A596-42B3-BAA5-8BE0EE0F327AQ39820896-4E578319-AE8B-410D-B3FF-9CACFC4D6503Q40857380-A0AA4E82-0BFB-4D0F-B8B2-50C0D653BB0E
P2860
Survival and long-term health and cognitive outcomes after low-grade glioma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Survival and long-term health and cognitive outcomes after low-grade glioma.
@ast
Survival and long-term health and cognitive outcomes after low-grade glioma.
@en
Survival and long-term health and cognitive outcomes after low-grade glioma.
@nl
type
label
Survival and long-term health and cognitive outcomes after low-grade glioma.
@ast
Survival and long-term health and cognitive outcomes after low-grade glioma.
@en
Survival and long-term health and cognitive outcomes after low-grade glioma.
@nl
prefLabel
Survival and long-term health and cognitive outcomes after low-grade glioma.
@ast
Survival and long-term health and cognitive outcomes after low-grade glioma.
@en
Survival and long-term health and cognitive outcomes after low-grade glioma.
@nl
P2093
P2860
P356
P1433
P1476
Survival and long-term health and cognitive outcomes after low-grade glioma.
@en
P2093
Amar Gajjar
David W Ellison
Deokumar Srivastava
E Brannon Morris
Gregory T Armstrong
Heather M Conklin
Leslie L Robison
Mary Ellen Hoehn
Melissa M Hudson
Robert Sanford
P2860
P304
P356
10.1093/NEUONC/NOQ178
P577
2010-12-22T00:00:00Z